
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
Brian Dobosh, Keivan Zandi, Diego Moncada Giraldo, et al.
Cell Reports (2022) Vol. 39, Iss. 11, pp. 110945-110945
Open Access | Times Cited: 16
Brian Dobosh, Keivan Zandi, Diego Moncada Giraldo, et al.
Cell Reports (2022) Vol. 39, Iss. 11, pp. 110945-110945
Open Access | Times Cited: 16
Showing 16 citing articles:
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 101
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 101
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 7
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 7
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV ‐2) binding to angiotensin‐converting enzyme 2
Junjie Zhu, Huimin Yan, Mengyao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3508-3521
Closed Access | Times Cited: 16
Junjie Zhu, Huimin Yan, Mengyao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3508-3521
Closed Access | Times Cited: 16
Transient anti-interferon autoantibodies in the airways are associated with efficient recovery from COVID-19
Benjamin Babcock, Astrid Kosters, Devon J. Eddins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Benjamin Babcock, Astrid Kosters, Devon J. Eddins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review)
Wen-Kai Li, Yunjing Zhuang, Songjun Shao, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 4
Wen-Kai Li, Yunjing Zhuang, Songjun Shao, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 4
Progranulin promotes regulatory T cells plasticity by mitochondrial metabolism through AMPK/PGC-1α pathway in ARDS
Yanqing Chen, Minkang Guo, Ke Xie, et al.
Clinical Immunology (2024) Vol. 261, pp. 109940-109940
Closed Access | Times Cited: 3
Yanqing Chen, Minkang Guo, Ke Xie, et al.
Clinical Immunology (2024) Vol. 261, pp. 109940-109940
Closed Access | Times Cited: 3
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV ‐2 targeting main protease and papain‐like protease
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, et al.
IUBMB Life (2023) Vol. 76, Iss. 5, pp. 228-241
Open Access | Times Cited: 7
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, et al.
IUBMB Life (2023) Vol. 76, Iss. 5, pp. 228-241
Open Access | Times Cited: 7
Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review
Yang Li, Lipeng Niu
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Yang Li, Lipeng Niu
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Sex differences and immune correlates of Long COVID development, persistence, and resolution
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19
Benjamin Babcock, Astrid Kosters, Devon J. Eddins, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Closed Access | Times Cited: 1
Benjamin Babcock, Astrid Kosters, Devon J. Eddins, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Closed Access | Times Cited: 1
Treatment of severe COVID-19: an evolving paradigm
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 17, pp. 1887-1891
Closed Access | Times Cited: 6
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 17, pp. 1887-1891
Closed Access | Times Cited: 6
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Remdesivir Inhibits Endothelial Activation and Atherosclerosis by Coupling TAL1 to TRAF6
Hanning Zhang, R. Li, Qianqian Huo, et al.
(2024)
Closed Access
Hanning Zhang, R. Li, Qianqian Huo, et al.
(2024)
Closed Access
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19
Tao Hu, Chi Hin Cho
Current Pharmaceutical Design (2022) Vol. 28, Iss. 22, pp. 1779-1779
Closed Access | Times Cited: 2
Tao Hu, Chi Hin Cho
Current Pharmaceutical Design (2022) Vol. 28, Iss. 22, pp. 1779-1779
Closed Access | Times Cited: 2
The impact of Omicron pandemic and COVID‐19 vaccination on the pancreatic adenocarcinoma patients
Ningzhen Fu, Yu Jiang, Zhiwei Xu, et al.
Aging and Cancer (2022) Vol. 3, Iss. 3-4, pp. 161-168
Open Access | Times Cited: 2
Ningzhen Fu, Yu Jiang, Zhiwei Xu, et al.
Aging and Cancer (2022) Vol. 3, Iss. 3-4, pp. 161-168
Open Access | Times Cited: 2